MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2018 International Congress

    Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy

    C. S P, V. Holla, S. Prasad, A. Stezin, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To systematically assess the specific Non-motor symptoms in Progressive Supranuclear Palsy using the Non Motor Symptom assessment scale (NMSS). Background: Progressive supranuclear palsy (PSP)…
  • 2018 International Congress

    The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy

    N. Matsuda, Y. Takamatsu, I. Aiba (Nagoya, Japan)

    Objective: This study aimed to elucidate the appropriate assessments associated with fall frequency in progressive supranuclear palsy (PSP). Background: PSP is an adult-onset neurodegenerative disease,…
  • 2018 International Congress

    Paraneoplastic and neuronal surface antibodies in Parkinson’s disease and atypical parkinsonian disorders

    R. Constantinescu, C. Malmeström, D. Krýsl, D. Jons, M. Axelsson (Gothenburg, Sweden)

    Objective: To investigate the prevalence of paraneoplastic and antineuronal antibodies in the serum and cerebrospinal fluid (CSF) from patients with Parkinson´s disease (PD) and atypical…
  • 2018 International Congress

    Cerebellar signs in progressive supranuclear palsy

    D. Crosiers, A. Sieben, J. Baets, J.J. Martin, P. Cras (Edegem, Belgium)

    Objective: To present a patient with cerebellar ataxia and a pathologically confirmed diagnosis of PSP. Background: Progressive supranuclear palsy (PSP) is an atypical form of…
  • 2018 International Congress

    Midbrain/pons area ratio and clinical features predict the prognosis of PSP

    S. Cui, S. Chen (Shanghai, People’s Republic of China)

    Objective: This study aims to characterize the natural history of PSP and to find predictors of shorter survival and early institutionalization including neuroimaging biomarkers. Background:…
  • 2018 International Congress

    Mineralization pattern of the deep gray matter by susceptibility-weighted magnetic resonance imaging to differentiate Parkinsonian disorders

    M. Modi, P. Singh (Chandigarh, India)

    Objective: To study mineralization pattern of the deep gray matter by susceptibility-weighted (SWI) magnetic resonance imaging to differentiate Parkinson’s disease and atypical parkinsonian disorders like…
  • 2018 International Congress

    Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism

    P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

    Objective: The aim of the work is to analyze whether combined examination of the frontal lobe using single photon emission computer tomography (SPECT) and Frontal…
  • 2018 International Congress

    Analysis of Tau Burden and Distribution on the Spectrum of PSP Subtypes

    J. Sanchez-Ruiz Gordoa, P. Clavero, M. Zelaya, C. López-Molina, A. Galbete, V. Coca, M. Mendioroz, E. Erro (Pamplona, Spain)

    Objective: The aim of this study was to assess the previous hypothesis about relationship between clinical spectrum of Progressive Supranuclear Palsy (PSP) and tau burden…
  • 2018 International Congress

    The difference in cerebellar blood flow reduction in multiple system atrophy and Parkinson’s disease

    N. Murakami, W. Sako, S. Haji, Y. Izumi, R. Kaji (Tokushima, Japan)

    Objective: The aim of this study is to determine if cerebral blood flow (CBF) reduction in the cerebellum could be a tool for differential diagnosis…
  • 2018 International Congress

    Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

    G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by loss of dopamine neurons in the substantia nigra. We measured neuroinflammatory marker fractalkine in…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Welcome to the MDS Abstracts Site
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • The hardest symptoms that bother patients with Parkinson's disease
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley